Mamu-A1*001 MHC-peptide tetramers were generated and tested for binding
to PBMC from SIV-infected animals. (A) A representative sequential gating
strategy for the flow cytometry data is shown. (B) Tetramer binding to PBMC from
three animals was tested; shown are the ELISPOT responses to each peptide
(STPESANLG, STPESANLGE, and TPESANLG are abbreviated as SG9, SE10, and TE9
respectively), and the percentage of CD8 T cells that were
tetramer-positive.